Herein, we studied the influence of the VEGFR2 signaling pathway controlled by MYOF in Caki-1, a metastatic CCRCC cell line, and discussed the prospective efficacy of ramucirumab in patients with CCRCC. Here, MYOF is linked to nonpapillary renal cell carcinoma.